Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is HealthCare Royalty Partners' primary investment focus?
- HealthCare Royalty Partners focuses on the Health Tech & Life Sciences sector, as indicated by their single recorded investment.
- When did HealthCare Royalty Partners make its first recorded investment?
- HealthCare Royalty Partners made its first recorded investment in February 2020.
- What was HealthCare Royalty Partners' most notable investment in 2020?
- In February 2020, HealthCare Royalty Partners invested $115 million in RedHill Biopharma, a company founded in 2009.
- What type of funding stage does HealthCare Royalty Partners participate in?
- HealthCare Royalty Partners has participated in Debt Financing rounds, with one such round recorded in February 2020.
- What is the typical investment amount for HealthCare Royalty Partners?
- Based on available data, HealthCare Royalty Partners' investment range is $115M - $115M, with their sole recorded investment being $115 million.
- Has HealthCare Royalty Partners acted as a lead investor in any rounds?
- According to startupim data, HealthCare Royalty Partners has not acted as a lead investor in any of its recorded investment rounds.
- How many portfolio companies does HealthCare Royalty Partners have?
- HealthCare Royalty Partners has one recorded portfolio company, RedHill Biopharma.
- What is HealthCare Royalty Partners' exit ratio?
- HealthCare Royalty Partners has an exit ratio of 0, indicating no recorded exits to date.